You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 10, 2025

Drug Price Trends for OXAPROZIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for OXAPROZIN

Average Pharmacy Cost for OXAPROZIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
OXAPROZIN 600 MG TABLET 69238-1120-01 0.41524 EACH 2025-01-22
OXAPROZIN 600 MG CAPLET 59762-6002-01 0.41524 EACH 2025-01-22
OXAPROZIN 600 MG TABLET 00185-0141-01 0.41524 EACH 2025-01-22
OXAPROZIN 600 MG TABLET 55111-0170-05 0.41524 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Oxaprozin Market Analysis and Price Projections

Overview of Oxaprozin

Oxaprozin is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for the treatment of various forms of arthritis, including osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis. It is known by brand names such as Daypro and Coxanto.

Market Dynamics

Current Market Value and Growth Projections

The oxaprozin market is experiencing significant growth, driven by increasing demand for effective anti-inflammatory medications. As of 2023, the oxaprozin market was valued at approximately $841.75 billion. It is projected to grow from $880.05 billion in 2024 to $1,255.92 billion by 2032, with an expected compound annual growth rate (CAGR) of around 4.55% during the forecast period from 2024 to 2032[1].

Market Drivers

Several factors are driving the growth of the oxaprozin market:

  • Rising Prevalence of Arthritis: The increasing prevalence of arthritis and post-operative pain conditions is driving the demand for effective analgesic treatments like oxaprozin[1].
  • Expansion of Healthcare Access: The growth of the pharmaceutical sector and increasing healthcare access globally are contributing to the market expansion[1].
  • Technological Advancements: Innovative drug delivery systems and the introduction of combination therapies are enhancing the efficacy and safety profiles of oxaprozin. Strategic collaborations between pharmaceutical companies and research institutions are also fostering innovation[4].

Market Restraints

Despite the positive outlook, the oxaprozin market faces several challenges:

  • Potential Side Effects and Drug Interactions: Oxaprozin's use can be limited by potential side effects and drug interactions[1].
  • Competition from Alternative Therapies: Competition from alternative pain management therapies and regulatory hurdles can impact market growth[1].
  • Regulatory Constraints: Regulatory challenges can delay the market entry of new formulations, affecting the overall market dynamics[4].

Market Segmentation

Dosage Forms

The oxaprozin market is segmented by dosage forms, including tablets, capsules, injections, and topical creams. Each form caters to different patient needs and preferences, contributing to the market's diversity[1].

End Users

The market is also segmented by end users, including hospitals, clinics, and pharmacies. These segments highlight the various channels through which oxaprozin is distributed and consumed[1].

Distribution Channels

Distribution channels such as direct sales and e-commerce are crucial for the market's growth. The expansion of online pharmacies has increased the accessibility of oxaprozin, making it easier for patients to obtain the medication[1].

Generic and Branded Oxaprozin

The market differentiates between generic and branded oxaprozin. Generic versions are often more affordable, while branded versions may offer additional features or formulations that justify their higher prices[1].

Regional Analysis

The oxaprozin market is analyzed across various regions, including North America, Europe, South America, Asia Pacific, and the Middle East and Africa. Each region presents unique market dynamics and opportunities:

  • North America: This region is a significant market due to high healthcare spending and a large patient population suffering from arthritis.
  • Europe: Europe also represents a substantial market, driven by advanced healthcare systems and high demand for anti-inflammatory medications.
  • Asia Pacific: This region is expected to show rapid growth due to increasing healthcare access and a large population base[1].

Key Players

Several key players are active in the oxaprozin market, including:

  • Aurobindo Pharma
  • Sandoz International GmbH
  • Abbott Healthcare
  • Pfizer
  • Glenmark Pharmaceuticals
  • Ranbaxy Laboratories
  • Sun Pharmaceutical Industries
  • Novartis[1].

These companies are focusing on enhancing product differentiation through innovative formulations and targeted delivery methods to capitalize on the growing market.

Price Analysis

The prices of oxaprozin vary based on the dosage form and the pharmacy:

  • 600 mg Oral Tablet: The cost for a supply of 60 tablets can range from $124.54 to $201.24, depending on the quantity and pharmacy[2].
  • 300 mg Oral Capsule: The cost for 60 capsules can be around $2,239.20, highlighting the variability in pricing based on the dosage form[2].

Coupons, Copay Cards, and Rebates

To make oxaprozin more affordable, various coupons, copay cards, and rebates are available. These offers can be in the form of printable coupons, savings cards, or free samples, which can significantly reduce the out-of-pocket costs for patients[2].

Strategic Recommendations

To capitalize on the growing oxaprozin market, companies should:

  • Enhance Product Differentiation: Focus on innovative formulations and targeted delivery methods to differentiate their products.
  • Expand Distribution Channels: Increase market reach by expanding distribution channels, particularly through online pharmacies and direct sales.
  • Invest in Research: Explore new therapeutic applications and address regulatory challenges to strengthen market position and drive growth[1].

Technological Advancements and Consumer Trends

Innovative Drug Delivery Systems

Recent technological advancements in drug delivery systems are enhancing the efficacy and safety profiles of oxaprozin. Combination therapies and novel formulations are catering to diverse patient needs, driving market growth[4].

Personalized Medicine

The shift towards personalized medicine is reshaping the landscape. Pharmaceutical companies are focusing on patient-centric approaches, driving the demand for customized formulations that address individual health needs[4].

Sustainability and Digital Health

The growing emphasis on sustainability within the pharmaceutical industry is prompting manufacturers to adopt eco-friendly practices. Additionally, the digitization of healthcare is improving patient engagement and adherence to treatment regimens through digital health solutions such as mobile applications and telemedicine[4].

Key Takeaways

  • The oxaprozin market is projected to grow significantly, driven by increasing demand for anti-inflammatory medications.
  • The market is segmented by dosage forms, end users, and distribution channels.
  • Key players are focusing on innovative formulations and expanding distribution channels.
  • Technological advancements and consumer trends towards personalized and sustainable medications are driving market growth.
  • Regulatory challenges and competition from alternative therapies are key restraints.

FAQs

What is oxaprozin used for?

Oxaprozin is used for the treatment of various forms of arthritis, including osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis.

What are the key drivers of the oxaprozin market?

The key drivers include the rising prevalence of arthritis, expansion of healthcare access, and technological advancements in drug delivery systems.

What are the challenges facing the oxaprozin market?

Challenges include potential side effects and drug interactions, competition from alternative therapies, and regulatory hurdles.

How is the oxaprozin market segmented?

The market is segmented by dosage forms (tablets, capsules, injections, topical creams), end users (hospitals, clinics, pharmacies), and distribution channels (direct sales, e-commerce).

What is the projected growth of the oxaprozin market?

The market is projected to grow from $880.05 billion in 2024 to $1,255.92 billion by 2032, with a CAGR of around 4.55% during the forecast period.

Who are the key players in the oxaprozin market?

Key players include Aurobindo Pharma, Sandoz International GmbH, Abbott Healthcare, Pfizer, Glenmark Pharmaceuticals, Ranbaxy Laboratories, Sun Pharmaceutical Industries, and Novartis.

Sources

  1. Oxaprozin Market Dynamics and Future Growth by 2032: Exclusive Report by WiseGuy Reports. OpenPR.
  2. Oxaprozin Prices, Coupons, Copay Cards & Patient Assistance. Drugs.com.
  3. Global Oxaprozin Market Forecast and Trend Analysis 2024-2031. STATS N DATA.
  4. Oxaprozin Market Overview and Leading Players: Therapicon, PD-Rx Pharmaceuticals, Pfizer, Neolpharma, Yichang Dongyangguang Changjiang Pharmaceutical, Helsinn, Apotex Corporation, Taisho. OpenPR.
  5. Generic OXAPROZIN INN entry, drug patent expiration information. Drug Patent Watch.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.